The Slow Cycling Phenotype: A Growing Problem for Treatment Resistance in Melanoma.

Abstract excerpt

Treatment resistance in metastatic melanoma is a longstanding issue. Current targeted therapy regimes in melanoma largely target the proliferating cancer population, leaving slow-cycling cancer cells undamaged. Consequently, slow-cycling cells are enriched upon drug therapy and can remain in the body for years until acquiring proliferative potential that triggers cancer relapse. Here we overview the molecular...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell Cycle
• Share to Chromatin Assembly and Disassembly
• Share to Energy Metabolism